Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior

BACKGROUND: Using other central nervous system (CNS) medications in combination with selective serotonin reuptake inhibitor (SSRI) treatment is common. Despite this, there is limited evidence on the impact on suicidal behavior of combining specific medications. We aim to provide evidence on signals...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagerberg, Tyra, Sjölander, Arvid, Gibbons, Robert D., Quinn, Patrick D., D’Onofrio, Brian M., Hellner, Clara, Lichtenstein, Paul, Fazel, Seena, Chang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682954/
https://www.ncbi.nlm.nih.gov/pubmed/36440412
http://dx.doi.org/10.3389/fpsyt.2022.1012650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682954/
https://www.ncbi.nlm.nih.gov/pubmed/36440412
http://dx.doi.org/10.3389/fpsyt.2022.1012650

Ejemplares similares